Metabolic Syndrome and the Endocrine Stress System

 

 Buy Article Permissions and Reprints

Abstract

Obesity constitutes one of the most serious public health problems, with rapidly increasing prevalence in western societies. Consequently, metabolic syndrome, a condition strongly associated with obesity, has become an epidemic problem. Recent studies have implicated chronic alterations to the stress system as playing a major role in the metabolic syndrome's pathophysiology. This brief review discusses the role of stress and hypothalamic-pituitary-adrenal axis dysfunction in the development of metabolic syndrome as well as new insights into the crosstalk between adipose tissue and endocrine stress system.

References

• 1 Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.  JAMA. 2002;  287 356-359
  CrossrefPubMedGoogle Scholar
• 2 Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.  Arch Intern Med. 2004;  164 1066-1076
  CrossrefPubMedGoogle Scholar
• 3 Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J. Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort.  Diabetes Care. 2004;  27 2135-2140
  PubMedGoogle Scholar
• 4 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) . Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).  JAMA. 2001;  285 2486-2497
  CrossrefPubMedGoogle Scholar
• 5 Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts?.  Circulation. 2003;  108 1546-1551
  CrossrefPubMedGoogle Scholar
• 6 Kopelman PG. Obesity as a medical problem.  Nature. 2000;  404 635-643
  CrossrefPubMedGoogle Scholar
• 7 Ravussin E, Valencia ME, Esparza J, Bennett PH, Schulz LO. Effects of a traditional lifestyle on obesity in Pima Indians.  Diabetes Care. 1994;  17 1067-1074
  PubMedGoogle Scholar
• 8 Rotimi CN, Cooper RS, Ataman SL, Osotimehin B, Kadiri S, Muna W, Kingue S, Fraser H, McGee D. Distribution of anthropometric variables and the prevalence of obesity in populations of west African origin: the International Collaborative Study on Hypertension in Blacks (ICSHIB).  Obes Res. 1995;  3 95-105
  PubMedGoogle Scholar
• 9 Hodge AM, Dowse GK, Toelupe P, Collins VR, Imo T, Zimmet PZ. Dramatic increase in the prevalence of obesity in western Samoa over the 13 year period 1978-1991.  Int J Obes Relat Metab Disord. 1994;  18 419-428
  PubMedGoogle Scholar
• 10 Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology.  2005;  30 1-10
  CrossrefPubMedGoogle Scholar
• 11 Chrousos GP, Gold PW. The concepts of stress and stress system disorders. Overview of physical and behavioral homeostasis.  JAMA. 1992;  267 1244-1252
  CrossrefPubMedGoogle Scholar
• 12 Bjorntorp P, Rosmond R. The metabolic syndrome - a neuroendocrine disorder?.  Br J Nutr. 2000;  83 49-57
  PubMedGoogle Scholar
• 13 Duclos M, Gatta B, Corcuff JB, Rashedi M, Pehourcq F, Roger P. Fat distribution in obese women is associated with subtle alterations of the hypothalamic-pituitary-adrenal axis activity and sensitivity to glucocorticoids.  Clin Endocrinol (Oxf). 2001;  55 447-454
  CrossrefPubMedGoogle Scholar
• 14 Weaver JU, Kopelman PG, McLoughlin L, Forsling ML, Grossman A. Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.  Clin Endocrinol (Oxf). 1993;  39 345-350
  CrossrefPubMedGoogle Scholar
• 15 Rosmond R, Dallman MF, Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities.  J Clin Endocrinol Metab. 1998;  83 1853-1859
  CrossrefPubMedGoogle Scholar
• 16 Bjorntorp P. Neuroendocrine factors in obesity.  J Endocrinol. 1997;  155 193-195
  CrossrefPubMedGoogle Scholar
• 17 Andrew R, Phillips DI, Walker BR. Obesity and gender influence cortisol secretion and metabolism in man.  J Clin Endocrinol Metab. 1998;  83 1806-1809
  CrossrefPubMedGoogle Scholar
• 18 L'Allemand D, Schmidt S, Rousson V, Brabant G, Gasser T, Gruters A. Associations between body mass, leptin, IGF-I and circulating adrenal androgens in children with obesity and premature adrenarche.  Eur J Endocrinol. 2002;  146 537-543
  CrossrefPubMedGoogle Scholar
• 19 Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, Carlsson B, Bouchard C, Bjorntorp P. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis.  Obes Res. 2000;  8 211-218
  PubMedGoogle Scholar
• 20 Jayo JM, Shively CA, Kaplan JR, Manuck SB. Effects of exercise and stress on body fat distribution in male cynomolgus monkeys.  Int J Obes Relat Metab Disord. 1993;  17 597-604
  PubMedGoogle Scholar
• 21 Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement.  J Clin Endocrinol Metab. 2003;  88 5593-5602
  CrossrefPubMedGoogle Scholar
• 22 Masuzaki H, Ogawa Y, Hosoda K, Miyawaki T, Hanaoka I, Hiraoka J, Yasuno A, Nishimura H, Yoshimasa Y, Nishi S, Nakao K. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome.  J Clin Endocrinol Metab. 1997;  82 2542-2547
  CrossrefPubMedGoogle Scholar
• 23 Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome?.  J Clin Endocrinol Metab. 2002;  87 998-1003
  CrossrefPubMedGoogle Scholar
• 24 Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management.  Endocr Rev. 2004;  25 309-340
  CrossrefPubMedGoogle Scholar
• 25 Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.  J Clin Endocrinol Metab. 2002;  87 2114-2120
  CrossrefPubMedGoogle Scholar
• 26 White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency.  Endocr Rev. 2000;  21 245-291
  CrossrefPubMedGoogle Scholar
• 27 Merke DP, Chrousos GP, Eisenhofer G, Weise M, Keil MF, Rogol AD, Van Wyk JJ, Bornstein SR. Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.  N Engl J Med. 2000;  343 1362-1368
  CrossrefPubMedGoogle Scholar
• 28 Glasow A, Haidan A, Hilbers U, Breidert M, Gillespie J, Scherbaum WA, Chrousos GP, Bornstein SR. Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin.  J Clin Endocrinol Metab. 1998;  83 4459-4466
  CrossrefPubMedGoogle Scholar
• 29 Pralong FP, Roduit R, Waeber G, Castillo E, Mosimann F, Thorens B, Gaillard RC. Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland.  Endocrinology. 1998;  139 4264-4268
  CrossrefPubMedGoogle Scholar
• 30 l'Allemand D, Penhoat A, Lebrethon MC, Ardevol R, Baehr V, Oelkers W, Saez JM. Insulin-like growth factors enhance steroidogenic enzyme and corticotropin receptor messenger ribonucleic acid levels and corticotropin steroidogenic responsiveness in cultured human adrenocortical cells.  J Clin Endocrinol Metab. 1996;  81 3892-3897
  CrossrefPubMedGoogle Scholar
• 31 Hauner H, Entenmann G, Wabitsch M, Gaillard D, Ailhaud G, Negrel R, Pfeiffer EF. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium.  J Clin Invest. 1989;  84 1663-1670
  PubMedGoogle Scholar
• 32 Rebuffe-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson JA, Bjorntorp P. Steroid hormone receptors in human adipose tissues.  J Clin Endocrinol Metab. 1990;  71 1215-1219
  PubMedGoogle Scholar
• 33 Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress.  Endocrinology. 1997;  138 3859-3863
  CrossrefPubMedGoogle Scholar
• 34 Papaspyrou-Rao S, Schneider SH, Petersen RN, Fried SK. Dexamethasone increases leptin expression in humans in vivo.  J Clin Endocrinol Metab. 1997;  82 1635-1637
  CrossrefPubMedGoogle Scholar
• 35 Wabitsch M, Jensen PB, Blum WF, Christoffersen CT, Englaro P, Heinze E, Rascher W, Teller W, Tornqvist H, Hauner H. Insulin and cortisol promote leptin production in cultured human fat cells.  Diabetes. 1996;  45 1435-1438
  CrossrefPubMedGoogle Scholar
• 36 Deng C, Moinat M, Curtis L, Nadakal A, Preitner F, Boss O, Assimacopoulos-Jeannet F, Seydoux J, Giacobino JP. Effects of beta-adrenoceptor subtype stimulation on obese gene messenger ribonucleic acid and on leptin secretion in mouse brown adipocytes differentiated in culture.  Endocrinology. 1997;  138 548-552
  CrossrefPubMedGoogle Scholar
• 37 Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting.  Nature. 1996;  382 250-252
  CrossrefPubMedGoogle Scholar
• 38 Licinio J, Mantzoros C, Negrao AB, Cizza G, Wong ML, Bongiorno PB, Chrousos GP, Karp B, Allen C, Flier JS, Gold PW. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function.  Nat Med. 1997;  3 575-579
  CrossrefPubMedGoogle Scholar
• 39 Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion.  J Clin Endocrinol Metab. 1998;  83 280-283
  CrossrefPubMedGoogle Scholar
• 40 Judd AM, Call GB, Barney M, McIlmoil CJ, Balls AG, Adams A, Oliveira GK. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion.  Ann N Y Acad Sci. 2000;  917 628-637
  PubMedGoogle Scholar
• 41 Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, Langenbach J, Willenberg HS, Barthel A, Hauner H, McCann SM, Scherbaum WA, Bornstein SR. Human adipocytes secrete mineralocorticoid-releasing factors.  Proc Natl Acad Sci U S A. 2003;  100 14211-14216
  CrossrefPubMedGoogle Scholar
• 42 Ehrhart-Bornstein M, Arakelyan K, Krug AW, Scherbaum WA, Bornstein SR. Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells.  Endocr Res. 2004;  30 865-870
  CrossrefPubMedGoogle Scholar
• 43 Seres J, Bornstein SR, Seres P, Willenberg HS, Schulte KM, Scherbaum WA, Ehrhart-Bornstein M. Corticotropin-releasing hormone system in human adipose tissue.  J Clin Endocrinol Metab. 2004;  89 965-970
  CrossrefPubMedGoogle Scholar
• 44 Hiroi N, Wong ML, Licinio J, Park C, Young M, Gold PW, Chrousos GP, Bornstein SR. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls.  Mol Psychiatry. 2001;  6 540-546
  CrossrefPubMedGoogle Scholar
• 45 Hsu SY, Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.  Nat Med. 2001;  7 605-611
  PubMedGoogle Scholar
• 46 Friedberg M, Zoumakis E, Hiroi N, Bader T, Chrousos GP, Hochberg Z. Modulation of 11 beta-hydroxysteroid dehydrogenase type 1 in mature human subcutaneous adipocytes by hypothalamic messengers.  J Clin Endocrinol Metab. 2003;  88 385-393
  CrossrefPubMedGoogle Scholar
• 47 Rask E, Olsson T, Soderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR. Tissue-specific dysregulation of cortisol metabolism in human obesity.  J Clin Endocrinol Metab. 2001;  86 1418-1421
  CrossrefPubMedGoogle Scholar
• 48 Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. A transgenic model of visceral obesity and the metabolic syndrome.  Science. 2001;  294 2166-2170
  CrossrefPubMedGoogle Scholar

Correspondence

Valéria Lamounier-ZepterMD 

Medical Clinic III·Technical University of Dresden·MTZ

room B.00.002·Fetscherstr. 74

01307 Dresden·Germany

Phone: +49/351/458 59 40

Phone: +49/351/458 66 05

Fax: +49/351/458 63 36

Email: valeria.zepter@uniklinikum-dresden.de